NCT00534794View on ClinicalTrials.gov

Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis

PHASE4CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

January 31, 2008

Conditions
Allergic Conjunctivitis
Interventions
DRUG

Elestat

Elestat BID for 2 days

DRUG

Pataday

Pataday QD for 2 days

Trial Locations (1)

02114

Ophthalmic Consultants of Boston, Boston

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00534794 - Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis | Biotech Hunter | Biotech Hunter